EEG Biofeedback for Treatment of Psychogenic Non-Epileptic Seizures (PNES) in Multiple Sclerosis: A Case Report

Overview

Journal Appl Psychophysiol Biofeedback

Publisher Springer

Date 2021 Jan 2

PMID 33386460

Citations 1

Authors

Fereshteh Shakibaei

Saied Sabaghypour

Farzaneh Fani Isfahani

Narges Darvishi Jazi

Affiliations

Soon will be listed here.

Abstract

The objective of the present study was to evaluate the effectiveness of EEG biofeedback for treatment of psychogenic non-epileptic seizures (PNES) in a patient with multiple sclerosis. The patient was a 47-year-old female who has been experiencing several PNES types after being diagnosed with multiple sclerosis. She underwent 16 sessions of the EEG biofeedback over a period of two months. Following EEG biofeedback, the patient reported that her PNES attacks had stopped and the treatment resulted in significant abatement in her clinical seizure symptoms. The analysis of sensorimotor rhythm (SMR) values revealed reduction of psychogenic non-epileptic seizure. The Beck Anxiety Inventory (BAI) and Word Health Organization Quality of Life Questionnaire (WHOQOL) were used before and after treatment. Decreased anxiety as well as increased quality of life was observed after treatment. Generally, the results indicated that EEG biofeedback was a useful procedure in treating PNES, promoting quality of life and reducing anxiety in our patient with multiple sclerosis.

Citing Articles

Training the brain to time: the effect of neurofeedback of SMR-Beta1 rhythm on time perception in healthy adults.

Behzadifard B, Sabaghypour S, Farkhondeh Tale Navi F, Nazari M Exp Brain Res. 2022; 240(7-8):2027-2038.

PMID: 35576072 DOI: 10.1007/s00221-022-06380-0.

References

Alsaadi T, Marquez A . Psychogenic nonepileptic seizures. Am Fam Physician. 2005; 72(5):849-56. View

Beck A, Epstein N, Brown G, Steer R . An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988; 56(6):893-7. DOI: 10.1037//0022-006x.56.6.893. View

Campos da Paz V, Garcia A, Campos da Paz Neto A, Tomaz C . SMR Neurofeedback Training Facilitates Working Memory Performance in Healthy Older Adults: A Behavioral and EEG Study. Front Behav Neurosci. 2019; 12:321. PMC: 6306463. DOI: 10.3389/fnbeh.2018.00321. View

Chen D, Sharma E, LaFrance Jr W . Psychogenic Non-Epileptic Seizures. Curr Neurol Neurosci Rep. 2017; 17(9):71. DOI: 10.1007/s11910-017-0781-7. View

Compston A, Coles A . Multiple sclerosis. Lancet. 2008; 372(9648):1502-17. DOI: 10.1016/S0140-6736(08)61620-7. View

Egner T, Sterman M . Neurofeedback treatment of epilepsy: from basic rationale to practical application. Expert Rev Neurother. 2006; 6(2):247-57. DOI: 10.1586/14737175.6.2.247. View

Fisher R, van Emde Boas W, Blume W, Elger C, Genton P, Lee P . Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005; 46(4):470-2. DOI: 10.1111/j.0013-9580.2005.66104.x. View

Gruzelier J . Differential effects on mood of 12-15 (SMR) and 15-18 (beta1) Hz neurofeedback. Int J Psychophysiol. 2013; 93(1):112-5. DOI: 10.1016/j.ijpsycho.2012.11.007. View

Hammond D . Neurofeedback with anxiety and affective disorders. Child Adolesc Psychiatr Clin N Am. 2004; 14(1):105-23, vii. DOI: 10.1016/j.chc.2004.07.008. View

10.

Howe R, STERMAN M . Cortical-subcortical EEG correlates of suppressed motor behavior during sleep and waking in the cat. Electroencephalogr Clin Neurophysiol. 1972; 32(6):681-95. DOI: 10.1016/0013-4694(72)90104-6. View

11.

Karakis I, Montouris G, Piperidou C, San Luciano M, Meador K, Cole A . Patient and caregiver quality of life in psychogenic non-epileptic seizures compared to epileptic seizures. Seizure. 2013; 23(1):47-54. DOI: 10.1016/j.seizure.2013.09.011. View

12.

Kwan P, Arzimanoglou A, Berg A, Brodie M, Hauser W, Mathern G . Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2009; 51(6):1069-77. DOI: 10.1111/j.1528-1167.2009.02397.x. View

13.

Lund C, Nakken K, Edland A, Celius E . Multiple sclerosis and seizures: incidence and prevalence over 40 years. Acta Neurol Scand. 2014; 130(6):368-73. DOI: 10.1111/ane.12276. View

14.

Marrie R, Reider N, Cohen J, Trojano M, Soelberg Sorensen P, Cutter G . A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis. Mult Scler. 2014; 21(3):342-9. PMC: 4429167. DOI: 10.1177/1352458514564486. View

15.

Nigro S . The Efficacy of Neurofeedback for Pediatric Epilepsy. Appl Psychophysiol Biofeedback. 2019; 44(4):285-290. DOI: 10.1007/s10484-019-09446-y. View

16.

OLDFIELD R . The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1971; 9(1):97-113. DOI: 10.1016/0028-3932(71)90067-4. View

17.

Reddy R, Rajeswaran J, Bhagavatula I, Kandavel T . Silent Epidemic: The Effects of Neurofeedback on Quality-of-Life. Indian J Psychol Med. 2014; 36(1):40-4. PMC: 3959017. DOI: 10.4103/0253-7176.127246. View

19.

Rejdak K, Jackson S, Giovannoni G . Multiple sclerosis: a practical overview for clinicians. Br Med Bull. 2010; 95:79-104. DOI: 10.1093/bmb/ldq017. View

20.

Sokic D, Stojsavljevic N, Drulovic J, Dujmovic I, Mesaros S, Ercegovac M . Seizures in multiple sclerosis. Epilepsia. 2001; 42(1):72-9. DOI: 10.1046/j.1528-1157.2001.48699.x. View

21.

Spatt J, Chaix R, Mamoli B . Epileptic and non-epileptic seizures in multiple sclerosis. J Neurol. 2001; 248(1):2-9. DOI: 10.1007/s004150170262. View